GLYC - Why GlycoMimetics Stock is Trading Higher Monday | Benzinga
GlycoMimetics, Inc. (NASDAQ:GLYC) stock is moving higher Monday after its chief medical officer disclosed the purchase of company stock.
The Details: On Tuesday, the chief medical officer Edwin Rock disclosed in a Form4 that he bought 305,000 shares of the company.
Rock purchased the shares at an average price of 26 cents.
How To Buy GlycoMimetics Stock
An investor can make a few decisions when deciding whether a stock is a good buy. In addition to valuation metrics and price action which you can find on Benzinga's quote pages – like GlycoMimetics‘s page for example – there are factors like whether or not a company pays a ...